FISMX | FTISX | FISMX / FTISX | |
Total Expense Ratio | 1.00 | 1.54 | 65% |
Annual Report Gross Expense Ratio | 1.00 | 1.54 | 65% |
Fund Existence | 23 years | 22 years | - |
Gain YTD | 21.543 | 21.141 | 102% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 5.07B | 5.07B | 100% |
Annual Yield % from dividends | 2.25 | 1.92 | 117% |
Returns for 1 year | 15.07 | 14.48 | 104% |
Returns for 3 years | 42.02 | 39.73 | 106% |
Returns for 5 years | 56.68 | 53.11 | 107% |
Returns for 10 years | 68.09 | 63.59 | 107% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRBRX | 141.34 | 1.72 | +1.23% |
Franklin Biotechnology Discovery R6 | |||
PSPFX | 4.56 | 0.02 | +0.44% |
US Global Investors Global Res | |||
SFLNX | 30.08 | -0.06 | -0.20% |
Schwab Fundamental US Large Company Idx | |||
STCZX | 17.64 | -0.04 | -0.23% |
Virtus Silvant Large-Cap Growth Stk R6 | |||
PSLIX | 30.41 | -0.13 | -0.43% |
Principal SmallCap Inst |